前收市價 | 4.5900 |
開市 | 4.6500 |
買盤 | 4.6800 x 300 |
賣出價 | 4.7200 x 600 |
今日波幅 | 4.5400 - 4.7900 |
52 週波幅 | 1.5700 - 8.4000 |
成交量 | |
平均成交量 | 1,645,971 |
市值 | 423.12M |
Beta 值 (5 年,每月) | 1.15 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.7700 |
業績公佈日 | 2024年5月06日 - 2024年5月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 15.60 |
Annexon (ANNX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Here is how Annexon, Inc. (ANNX) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
In this article, we will take a detailed look at the 10 Buy-Rated Stocks with Latest Insider Purchases. For a quick overview of such stocks, read our article 5 Buy-Rated Stocks with Latest Insider Purchases. Insider trading and its relationship with stock returns is a topic that has interested researchers for a long time. When insiders buy their own […]